禾豐牧業(603609.SH):擬對控股子公司太行禾豐增資2480萬元
格隆匯 10 月 26日丨禾豐牧業(603609.SH)公告,2020年5月9日,公司與恩康牧業共同出資設立河北太行禾豐牧業有限公司,註冊資本8000萬元,其中公司出資4960萬元,持股62%;恩康牧業出資3040萬元,持股38%。為進一步滿足項目資金需求,太行禾豐擬進行增資擴股,註冊資本由8,000萬元增加至1.2億元。各股東同比例增資,公司持股62%,增資2480萬元;恩康牧業持股38%,增資1520萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.